Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYT997 + Carboplatin in Relapsed Glioblastoma
NCT00650949Phase 2Terminated
- Sponsor
- Gilead Sciences
- Start
- Nov 2009
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Lexibulin in glioblastoma multiforme (GBM), sponsored by Gilead Sciences. Started Nov 2009; status: terminated.
02
Drugs
Lexibulin
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00650949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00650949.